Related Experiment Videos
Pediatric intracranial hemangioendotheliomas: case report
T C Chen1, I Gonzalez-Gomez, F H Gilles
1Division of Neurosurgery, Children's Hospital of Los Angeles, California, USA.
Neurosurgery
|February 1, 1997
Summary
Intracranial hemangioendotheliomas are rare pediatric tumors. Complete surgical removal offers a cure, while interferon alpha-2a can manage unresectable lesions, ensuring long-term survival.
Area of Science:
- Neuro-oncology
- Pediatric Neurosurgery
- Vascular Tumors
Background:
- Intracranial hemangioendotheliomas are rare vascular tumors, particularly in children.
- Accurate diagnosis is crucial for effective treatment and prognosis.
- These tumors require consideration in the differential diagnosis of intracranial neoplasms.
Observation:
- Two pediatric cases are presented: a 7-year-old with a gasserian ganglion lesion and a 3-month-old with a cervicomedullary junction tumor.
- The 7-year-old achieved a complete cure via gross total resection.
- The 3-month-old underwent partial resection followed by interferon alpha-2a, resulting in tumor size reduction.
Findings:
- Complete surgical excision is curative for intracranial hemangioendotheliomas.
- Interferon alpha-2a effectively controls residual tumor growth in unresectable cases.
- Both patients demonstrated no recurrence or progression over a 4-year follow-up period.
Implications:
- Surgical resection is the primary treatment for intracranial hemangioendotheliomas.
- Interferon alpha-2a serves as a viable adjunctive therapy for residual or unresectable tumors.
- These findings support long-term survival and management strategies for pediatric intracranial hemangioendotheliomas.